Electrovaya Reports Strong Q2 FY2026 Results with 20% Revenue Growth and Chairman's $15.3M Warrant Exercise
summarizeSummary
Electrovaya reported strong Q2 FY2026 financial results with 20% revenue growth and a 404% increase in six-month net profit, alongside a significant $15.3 million warrant exercise by the Chairman and continued strategic progress.
check_boxKey Events
-
Strong Q2 FY2026 Financial Performance
Reported 20% year-over-year revenue growth to $18.0 million and a 23% increase in net profit to $1.0 million for the quarter. Six-month net profit surged 404% to $2.1 million.
-
Significant Balance Sheet Improvement
Cash and cash equivalents increased from $6.4 million to $20.4 million, and total equity more than doubled from $31.1 million to $62.8 million since September 30, 2025.
-
Chairman Exercises Warrants for $15.3 Million
Dr. Sankar Das Gupta, Chairman and Director, exercised 1,420,000 warrants at Cdn $0.90 per share, equivalent to approximately $15.3 million based on the current stock price, indicating strong insider conviction.
-
Strategic Progress on Jamestown Facility
The company continues the build-out of its Jamestown gigafactory, drawing down on the $50.8 million EXIM loan and increasing deposits for equipment, with commercial cell manufacturing targeted for early FY2027.
auto_awesomeAnalysis
Electrovaya Inc. reported robust financial results for Q2 FY2026, demonstrating significant operational improvements and growth. Revenue increased by 20% year-over-year, with net profit surging by 23% for the quarter and an impressive 404% for the six-month period. The company also substantially strengthened its balance sheet, more than doubling its equity and significantly increasing cash reserves. This strong performance is further underscored by the Chairman's exercise of warrants valued at approximately $15.3 million, signaling strong insider confidence. Progress on the Jamestown gigafactory, UL certifications, and participation in a DOE-funded project highlight strategic execution and future growth potential.
At the time of this filing, ELVA was trading at $10.77 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $530.3M. The 52-week trading range was $2.75 to $11.88. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.